Publications

18

Feb, 2001

Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T+ddI+Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants : 24 Week Preliminary Results from the PENTA 7 Study.

 

Authors: Faye A , Compagnucci A., Saidi Y. for the PENTA 7 Executive Committee

Published in: 8th Conference on Retroviruses and Opportunistic Infections, Chicago 4-8 February 2001 Poster 678

Read

18

Jul, 2000

Nelfinavir doses should be increased in infants less than 3 months.

 

Authors: Litalien C. Giaquinto C. Faye A. Mechinaud F. Grosch I. Compagnucci A. Jacqz-Aigrain E.

Published in: XIII International AIDS Conference, Durban, South Africa, 9-14 July 2000. Abstract Mo PEB 2213

Read

19

Apr, 2000

Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis

 

Authors: Sharland M, Gibb DM, Giaquinto C.

Published in: European Journal of Pediatrics 2000; 159:649-656.

Read

19

Apr, 2000

Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.

 

Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P.

Published in: European Journal of Pediatrics 2000; 159(3):170-5

Read

18

Apr, 2000

Reconstitution of the T-cell Pool in Treated, HIV-infected Children.

 

Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E.

Published in: 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, January 30- February 2, 2000. Abstract 322.

18

Apr, 2000

Immune repopulation after HAART in previously untreated HIV-1 infected children.

 

Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A

Published in: The Lancet 2000; 355: 1331-2.

Read

18

Apr, 2000

A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial.

 

Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee.

Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published in AIDS 2000, Vol 14, supp4 p.58 (abstractPL6.8)

18

Apr, 2000

Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)

 

Authors: Kaye S. on behalf of the PENTA Virology Committee.

Published in: 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000. Poster 308.

1

Oct, 1999

Parents’ attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. Paediatric European Network for Treatment of AIDS.

 

The study aimed to explore the experience of parents/care-givers to their child’s participation in a European randomized trial of immediate (zidovudine) with deferred (placebo) antiretroviral treatment in asymptomatic children with vertically acquired HIV infection (PENTA 1 trial).

Published in: HIV Med. 1999;1(1):25-31.

 

Read

18

Apr, 1998

Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial).

 

Authors:  Kaye S, Loveday C, Gibb DM., Newberry A.

Published in: IVth International Congress Glasgow, 8-12 November 1998. Abstract P305